COMBINATION OF IL-4 / IL-13 PATHWAY INHIBITORS AND PLASMA CELL ABLATION TO TREAT AN ALLERGY

MA55372AUndetermined Publication Date: 2022-01-26REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA55372
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-01-06
Filing Date
2020-03-20
Publication Date
2022-01-26
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.